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because bacteria could have been
transported to Chile by ballast water
from the Northern Hemisphere
(1,4,6). As in previous outbreaks,
shellfish responsible for this epidemic
were harvested near international
shipping lanes (1,3,4,6). The appear-
ance of V.  parahaemolyticus O3:K6
in Chile has thus converted the expan-
sion of this strain into a real pandem-
ic because this vibrio is now present
in 5 continents. The persistence of V.
parahaemolyticus in Region X might
also have been encouraged by an
expansion of finfish and shellfish
aquaculture in that area. As in other
parts of the world, expansion of these
food industries could provide physical
and nutritional substrates for vibrios
to persist and propagate when growth
is triggered by increases in tempera-
ture of seawater (1,2,8). 
Emergence of V. parahaemolyti-
cus in Region X has also coincided
with expansion of harmful algal
blooms in the same area. These
blooms are triggered by increases in
seawater temperature and degradation
of the coastal environment (9,10). A
connection has been established
between algal blooms and the pres-
ence of V. cholerae and cholera epi-
demics in the Gulf of Bengal and off
the coast of Peru at the start of the
Latin America epidemic (10). Further
research is necessary to ascertain
whether persistence of V.  para-
haemolyticus and epidemics are relat-
ed to algal blooms in this region of
Chile.
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Toxoplasma gondii
Prevalence, United
States 
To the Editor: We correct the
prevalence of Toxoplasma gondii
immunoglobulin (Ig) G antibodies
published in Emerging Infectious
Diseases in 2003 (1). An incorrect
cutoff value in the computer program
used to calculate seropositivity of
anti–T. gondii IgG antibody resulted
in some incorrect prevalence rates.
We discovered this error when analyz-
ing more recent National Health and
Nutrition Examination Survey
(NHANES) data. 
The cutoff value for anti–T.
gondii IgG seropositivity used in the
prior publication (1) was >6 IU,
which is the correct value for
NHANES III 1988–1994 data (2) but
not for NHANES 1999–2000 data.
Because of a change by the T. gondii
test kit manufacturer, the cutoff value
for NHANES 1999–2000 seropositiv-
ity data was increased to >10 IU. This
cutoff change from >6 to >10 IU does
not cause a large difference in the T.
gondii seroprevalence reported. In
addition, it does not change the over-
all findings of the article or the over-
all relationship between NHANES III
(1988–1994) and NHANES 1999–
2000. However, it does produce a bor-
derline change for 2 demographic
subgroups (non-Hispanic white per-LETTERS
sons and persons born in the United
States), for whom the difference from
NHANES III to NHANES 1999–
2000 data reached statistical signifi-
cance at p<0.05 in the t test, but the
95% confidence intervals (CIs) for the
prevalence estimates for these groups
still overlapped between NHANES III
and NHANES 1999–2000 (i.e., the t
test is a less conservative measure of
association than CI). 
After this correction, the overall
age-adjusted  T. gondii antibody
prevalence according to NHANES
1999–2000 data changed from 15.8%
(95% CI 13.5%–18.1%) to 14.3%
(95% CI 12.3%–16.2%). The Table
shows the overall and stratified sero-
prevalence rates for NHANES
1999–2000 (corrected) compared
with NHANES III (no corrections
needed). 
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Human Infection
with Schineria 
larvae
To the Editor: Myiasis remains
prevalent worldwide (1,2) and is
infestation by larvae from fly species
of live or dead tissues from vertebrate
hosts (1,3,4). In humans, myiasis
most frequently causes infection of
exposed ulcers or traumatic wounds
(1). In industrialized countries, most
cases occur in tourists returning from
tropical and subtropical areas (5,6),
but autochthonous cases still exist.
Several bacterial species have been
associated with fly larvae, including
species of the family Enterobac-
teriaceae and, more recently,
Schineria larvae (7,8).  S. larvae, a
gram-negative bacterium, has been
grown from larvae of Wohlfahrtia
magnifica, a fly species responsible
for myiasis (7,8). Its 16S rRNA gene
has been amplified from a bacterial
community of species involved in aer-
obic thermophilic bioprocesses (9).
We report a case of S. larvae bac-
teremia in a man with wound myiasis.
On June 12, 2006, a 76-year-old
man who had type 2 diabetes mellitus
was examined at the emergency
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